What Decoy Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 2 |
| Sells | 0 | 2 |
| Total trades | 10 | 14 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 65,253 | 67,526 |
| Disposed | 0 | 2 |
| Net activity | +65,253 | +67,523 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Gauthier Patricia G. | Director | Aug 31 | Grant / award · A | +2,000 | — | — | 2,000 |
| Hibner Barbara Louise | Chief Scientific Officer | Aug 31 | Grant / award · A | +4,216 | — | — | 4,216 |
| McVicar William K. | Director | Aug 31 | Grant / award · A | +3,000 | — | — | 3,002 |
| Burleson Tess | Director | Aug 31 | Grant / award · A | +2,000 | — | — | 2,002 |
| Marschel Peter Klaus | Chief Business Officer | Aug 31 | Grant / award · A | +3,900 | — | — | 3,900 |
| Rosenblum Mark J | Chief Financial Officer | Aug 31 | Grant / award · A | +9,682 | — | — | 11,363 |
| Pierce Frederick Ii | Chief Executive Officer | Aug 31 | Grant / award · A | +33,455 | — | — | 34,844 |
| Hanish Arnold C | Director | Aug 31 | Grant / award · A | +3,000 | — | — | 3,418 |
| Lieber Jonathan I | Director | Aug 31 | Grant / award · A | +2,000 | — | — | 2,002 |
| Lammers Paul | Director | Aug 31 | Grant / award · A | +2,000 | — | — | 2,001 |
| Hanish Arnold C | Director | Dec 30 | Open-market sale · S | −12 | $0.64 | −$7.68 | 0 |
| Hanish Arnold C | Director | Dec 30 | Open-market sale · S | −15 | $0.64 | −$9.6 | 5,000 |
| Hanish Arnold C | Director | Nov 20 | Open-market buy · P | +5,000 | $0.75 | +$3.74K | 5,015 |
| Rosenblum Mark J | Exec VP Finance, CFO | Nov 20 | Open-market buy · P | +20,000 | $0.80 | +$16K | 20,177 |
| Rosenblum Mark J | Exec VP Finance, CFO | Feb 13 | Grant / award · A | +6,432 | — | — | 21,851 |
| Arthur David J. | Chief Executive Officer | Feb 13 | Grant / award · A | +14,300 | — | — | 48,019 |
| Rosenblum Mark J | Exec VP Finance, CFO | Jan 03 | Grant / award · A | +8,000 | — | — | 15,419 |
| Lammers Paul | Director | Jan 03 | Grant / award · A | +1,440 | — | — | 1,718 |
| Hanish Arnold C | Director | Jan 03 | Grant / award · A | +1,440 | — | — | 1,440 |
| Lieber Jonathan I | Director | Jan 03 | Grant / award · A | +1,440 | — | — | 2,940 |
Loading...
